VANCOUVER, British Columbia, May 09, 2019 — Roadman Investments Corp. (LITT.V)(1QD.F)(OTC:RMANF) (“Roadman Investments” or the “Company”) applauds Denver, Colorado’s recent decriminalization of psilocybin; the active psychoactive ingredient contained in psychedelic mushrooms.
On May 8th, 2019, Denver voters approved Initiative 301, a measure that prohibits the City’s government from deploying resources to impose criminal penalties relating to the consumption and possession of psilocybin by adults over 21 years of age.
This passage of Initiative 301 comes amid a recent resurgence in the study of psilocybin and its potential medical applications. Researchers worldwide are increasingly examining whether psilocybin may alleviate symptoms associated with conditions such as anxiety, obsessive-compulsive disorder, major depressive disorder and alcohol dependence.
London-based start-up, Compass Pathways (“Compass”), has produced 20,000 individual does of psilocybin for use in clinical trials across North America and Europe. Compass boasts an advisory board of esteemed scientists and has attracted high profile funding from Peter Thiel, Christian Angermayer and Mike Novogratz, among others.
Luke Montaine, Chief Executive Officer and a Director of Roadman, stated: “Roadman applauds the progressive voters of Denver and the recent passage of Initiative 301. Psilocybin has become a promising candidate for future treatments for anxiety and depression because it appears to disrupt the sorts of engrained brain activity patterns that are the hallmark of those diseases.
“Leveraging its newly formed Health and Wellness committee, Roadman will look to actively pursue investments within this sector. The global mushroom market accounted for US$38.13 billion in 2017 and is forecasted to expand at a CAGR of 7.9% from 2018 to 2026. This growth will be further bolstered by the increasing demand for meat substitutes, as well as shifting consumer preference towards vegan foods”.
About Roadman Investments
Roadman Investments is mandated with realizing alpha returns for its shareholders via the tactical deployment of capital across the resource, agricultural, financial services, technology and health and wellness verticals.
For further information, please contact:
+1 (778) 772-1751
Learn more about Roadman by visiting our website at: https://roadmancorp.com/
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements – This news release contains certain forward-looking statements, including statements regarding the business of the Company. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements. The Company does not undertake to update any forward-looking statements, oral or written, made by itself or on its behalf except as required by law.